The ability of acute injection of human-specific anti-tau and anti-Aß antibodies to rapidly reverse the persistent synaptic plasticity disruption caused by AD brain extract points to the continued presence of synaptotoxic tau and Aß species. The gene discussed is MAPT; the disease is Alzheimer disease.